Rua Bioscience Limited (NZE:RUA)

Market Cap	10.14M +61.9%
Revenue (ttm)	2.39M +124.8%
Net Income	-3.45M
EPS	-0.01
Shares Out	338.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,778
Open	0.0300
Previous Close	0.0300
Day's Range	0.0300 - 0.0300
52-Week Range	0.0240 - 0.0590
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2026

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in seed production and genetic discovery related activities. In addition, it engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Employees: 30
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In fiscal year 2025, Rua Bioscience's revenue was 1.83 million, an increase of 477.39% compared to the previous year's 316,350. Losses were -3.46 million, -74.81% less than in 2024.